Abstract
The human rhinovirus 14 (HRV14) protomer, with or without the antiviral compound WIN 52084s, was simulated using molecular dynamics and rotational symmetry boundary conditions to model the effect of the entire icosahedral capsid. The protein asymmetrical unit, comprising four capsid proteins (VP1, VP2, VP3, and VP4) and two calcium ions, was solvated both on the exterior and the interior to fill the inside of the capsid. The stability of the simulations of this large system (~800 residues and 6,650 water molecules) is comparable to more conventional globular protein simulations. The influence of the antiviral compound on compressibility and positional fluctuations is reported. The compressibility, estimated from the density fluctuations in the region of the binding pocket, was found to be greater with WIN 52084s bound than without the drug, substantiating previous computations on reduced viral systems. An increase in compressibility correlates with an entropically more favorable system. In contrast to the increase in density fluctuations and compressibility, the positional fluctuations decreased dramatically for the external loops of VP1 and the N-terminus of VP3 when WIN 52084s is bound. Most of these VP1 and VP3 loops are found near the fivefold axis, a region whose mobility was not considered in reduced systems, but can be observed with this simulation of the full viral protomer. Altered loop flexibility is consistent with changes in proteolytic sensitivity observed experimentally. Moreover, decreased flexibility in these intraprotomeric loops is noteworthy since the externalization of VP4, part of VP1, and RNA during the uncoating process is thought to involve areas near the fivefold axis. Both the decrease in positional fluctuations at the fivefold axis and the increase in compressibility near the WIN pocket are discussed in relationship to the antiviral activity of stabilizing the virus against uncoating.
MeSH Terms
Antiviral Agents/chemistry,pharmacology
Biophysical Phenomena
Biophysics
Calcium/chemistry
Capsid/chemistry,drug effects
Humans
In Vitro Techniques
Isoxazoles/chemistry,pharmacology
Macromolecular Substances
Models, Molecular
Protein Conformation
Protein Structure, Quaternary
Rhinovirus/chemistry,drug effects
Thermodynamics
Chemicals
Antiviral Agents
Isoxazoles
Macromolecular Substances
Win 52084
Calcium
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Speelman B
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907-1333, USA.
Brooks B R
Post C B
References (35)
35 references, click to expand
-
Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus.
Protein Sci. 1999 Nov;8(11):2281-9
PMID: 10595531
-
Activity of pleconaril against enteroviruses.
Antimicrob Agents Chemother. 1999 Sep;43(9):2109-15
PMID: 10471549
-
The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses.
Structure. 1999 Dec 15;7(12):1527-38
PMID: 10647183
-
Stabilization of poliovirus by capsid-binding antiviral drugs is due to entropic effects.
J Mol Biol. 2000 Feb 18;296(2):335-40
PMID: 10669591
-
Theoretical studies of viral capsid proteins.
Curr Opin Struct Biol. 2000 Apr;10(2):170-3
PMID: 10753813
-
Structure of a human common cold virus and functional relationship to other picornaviruses.
Nature. 1985 Sep 12-18;317(6033):145-53
PMID: 2993920
-
Three-dimensional structure of poliovirus at 2.9 A resolution.
Science. 1985 Sep 27;229(4720):1358-65
PMID: 2994218
-
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.
Science. 1986 Sep 19;233(4770):1286-93
PMID: 3018924
-
Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
Antimicrob Agents Chemother. 1986 Jul;30(1):110-6
PMID: 3019232
-
Molecular dynamics simulations of native and substrate-bound lysozyme. A study of the average structures and atomic fluctuations.
J Mol Biol. 1986 Aug 5;190(3):455-79
PMID: 3783708
-
Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.
Proc Natl Acad Sci U S A. 1988 May;85(10):3304-8
PMID: 2835768
-
Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors.
J Virol. 1989 May;63(5):2002-7
PMID: 2539499
-
Computer simulation study of the binding of an antiviral agent to a sensitive and a resistant human rhinovirus.
J Comput Aided Mol Des. 1989 Jan;2(4):259-66
PMID: 2541225
-
Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.
J Virol. 1990 May;64(5):1934-45
PMID: 2157861
-
A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids.
J Gen Virol. 1991 Sep;72 ( Pt 9):2153-7
PMID: 1716654
-
Molecular dynamics of HIV-1 protease.
Proteins. 1992 Jul;13(3):175-94
PMID: 1603808
-
Ion channels in icosahedral virus: a comparative analysis of the structures and binding sites at their fivefold axes.
Biophys J. 1992 Oct;63(4):1133-45
PMID: 1384743
-
Structure of a human rhinovirus complexed with its receptor molecule.
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):507-11
PMID: 8093643
-
WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present.
J Virol. 1993 Mar;67(3):1246-54
PMID: 8382293
-
Escherichia coli-derived rat intestinal fatty acid binding protein with bound myristate at 1.5 A resolution and I-FABPArg106-->Gln with bound oleate at 1.74 A resolution.
J Biol Chem. 1993 Dec 15;268(35):26375-85
PMID: 8253762
-
Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.
J Virol. 1994 Jun;68(6):3965-70
PMID: 7514682
-
Human rhinovirus 14 complexed with fragments of active antiviral compounds.
Virology. 1994 Jul;202(1):360-9
PMID: 8009848
-
Structural studies on human muscle fatty acid binding protein at 1.4 A resolution: binding interactions with three C18 fatty acids.
Structure. 1994 Jun 15;2(6):523-34
PMID: 7922029
-
Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.
Curr Biol. 1994 Sep 1;4(9):784-97
PMID: 7820548
-
The structure of coxsackievirus B3 at 3.5 A resolution.
Structure. 1995 Jul 15;3(7):653-67
PMID: 8591043
-
Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
J Mol Biol. 1995 Oct 13;253(1):61-73
PMID: 7473717
-
A novel basis of capsid stabilization by antiviral compounds.
J Mol Biol. 1995 Dec 8;254(4):544-51
PMID: 7500332
-
VMD: visual molecular dynamics.
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
PMID: 8744570
-
Adenylate kinase motions during catalysis: an energetic counterweight balancing substrate binding.
Structure. 1996 Feb 15;4(2):147-56
PMID: 8805521
-
Cations in human rhinoviruses.
Virology. 1997 Jan 6;227(1):13-23
PMID: 9007054
-
The pentamer channel stiffening model for drug action on human rhinovirus HRV-1A.
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2466-71
PMID: 9122218
-
Influence of an antiviral compound on the temperature dependence of viral protein flexibility and packing: a molecular dynamics study.
J Mol Biol. 1998 Feb 20;276(2):331-7
PMID: 9512706
-
Antiviral agent blocks breathing of the common cold virus.
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6774-8
PMID: 9618488
-
Picornaviruses: epitopes, canyons, and pockets.
Adv Virus Res. 1999;52:1-23
PMID: 10384234
-
Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus.
J Virol. 2000 Feb;74(3):1342-54
PMID: 10627545